These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
344 related articles for article (PubMed ID: 12841924)
21. Comparative efficacy and safety of azelastine and levocabastine nasal sprays in patients with seasonal allergic rhinitis. Falser N; Wober W; Rahlfs VW; Baehre M Arzneimittelforschung; 2001; 51(5):387-93. PubMed ID: 11413739 [TBL] [Abstract][Full Text] [Related]
22. Dose-dependent protection by azelastine eye drops against pollen-induced allergic conjunctivitis. A double-blind, placebo-controlled study. Horak F; Berger UE; Menapace R; Toth J; Stübner PU; Marks B Arzneimittelforschung; 1998 Apr; 48(4):379-84. PubMed ID: 9608880 [TBL] [Abstract][Full Text] [Related]
23. Topical antihistamines and mast cell stabilisers for treating seasonal and perennial allergic conjunctivitis. Castillo M; Scott NW; Mustafa MZ; Mustafa MS; Azuara-Blanco A Cochrane Database Syst Rev; 2015 Jun; 2015(6):CD009566. PubMed ID: 26028608 [TBL] [Abstract][Full Text] [Related]
24. Comparison of efficacy of bromfenac sodium 0.1% ophthalmic solution and fluorometholone 0.02% ophthalmic suspension for the treatment of allergic conjunctivitis. Fujishima H; Fukagawa K; Takano Y; Tanaka M; Okamoto S; Miyazaki D; Yamada J; Fukushima A; Uchio E; Nakagawa Y J Ocul Pharmacol Ther; 2009 Jun; 25(3):265-70. PubMed ID: 19348602 [TBL] [Abstract][Full Text] [Related]
26. A comparison of the efficacy of azelastine nasal spray and loratidine tablets in the treatment of seasonal allergic rhinitis. Gambardella R J Int Med Res; 1993; 21(5):268-75. PubMed ID: 7906659 [TBL] [Abstract][Full Text] [Related]
27. Levocabastine. An update of its pharmacology, clinical efficacy and tolerability in the topical treatment of allergic rhinitis and conjunctivitis. Noble S; McTavish D Drugs; 1995 Dec; 50(6):1032-49. PubMed ID: 8612470 [TBL] [Abstract][Full Text] [Related]
28. Efficacy and safety of topical azelastine compared with topical mitomycin C in patients with allergic conjunctivitis. Sodhi PK; Pandey RM; Ratan SK Cornea; 2003 Apr; 22(3):210-3. PubMed ID: 12658084 [TBL] [Abstract][Full Text] [Related]
29. Efficacy of olopatadine HCI 0.1%, ketotifen fumarate 0.025%, epinastine HCI 0.05%, emedastine 0.05% and fluorometholone acetate 0.1% ophthalmic solutions for seasonal allergic conjunctivitis: a placebo-controlled environmental trial. Borazan M; Karalezli A; Akova YA; Akman A; Kiyici H; Erbek SS Acta Ophthalmol; 2009 Aug; 87(5):549-54. PubMed ID: 18631332 [TBL] [Abstract][Full Text] [Related]
30. Efficacy and tolerability of ophthalmic epinastine: a randomized, double-masked, parallel-group, active- and vehicle-controlled environmental trial in patients with seasonal allergic conjunctivitis. Whitcup SM; Bradford R; Lue J; Schiffman RM; Abelson MB Clin Ther; 2004 Jan; 26(1):29-34. PubMed ID: 14996515 [TBL] [Abstract][Full Text] [Related]
31. Comparative efficacy of azelastine nasal spray and terfenadine in seasonal and perennial rhinitis. Gastpar H; Nolte D; Aurich R; Brendt P; Enzmann H; Giesemann G; Kunkel G; Petzold U; Renz W; Schata M Allergy; 1994 Mar; 49(3):152-8. PubMed ID: 7911010 [TBL] [Abstract][Full Text] [Related]
32. Evaluation of the drug monitoring programme of azelastine hydrochloride nasal spray in the treatment of allergic rhinitis in children under 13 years of age. Wober W; Diez Crespo CD; Bähre M Arzneimittelforschung; 1997 Jul; 47(7):841-4. PubMed ID: 9272242 [TBL] [Abstract][Full Text] [Related]
33. Effectiveness of azelastine nasal spray compared with oral cetirizine in patients with seasonal allergic rhinitis. Corren J; Storms W; Bernstein J; Berger W; Nayak A; Sacks H; Clin Ther; 2005 May; 27(5):543-53. PubMed ID: 15978303 [TBL] [Abstract][Full Text] [Related]
34. Efficacy of azelastine nasal spray in seasonal allergic rhinitis patients who remain symptomatic after treatment with fexofenadine. LaForce CF; Corren J; Wheeler WJ; Berger WE; Ann Allergy Asthma Immunol; 2004 Aug; 93(2):154-9. PubMed ID: 15328675 [TBL] [Abstract][Full Text] [Related]
35. Effects of olopatadine hydrochloride nasal spray 0.6% in the treatment of seasonal allergic rhinitis: a phase III, multicenter, randomized, double-blind, active- and placebo-controlled study in adolescents and adults. Shah SR; Nayak A; Ratner P; Roland P; Michael Wall G Clin Ther; 2009 Jan; 31(1):99-107. PubMed ID: 19243710 [TBL] [Abstract][Full Text] [Related]
36. A comparison of topical mequitazine and disodium cromoglycate in allergic conjunctivitis induced by a specific conjunctival provocation test. Dupin O; Trinquand C; Persi L; Bousquet J; Robert F; Arnaud B Eur J Ophthalmol; 2000; 10(1):15-21. PubMed ID: 10744200 [TBL] [Abstract][Full Text] [Related]
37. Efficacy of epinastine hydrochloride ophthalmic solution in allergic conjunctivitis by conjunctival cedar pollen allergen challenge. Fujishima H; Ohashi Y; Takamura E Ann Allergy Asthma Immunol; 2014 Oct; 113(4):476-81. PubMed ID: 25163405 [TBL] [Abstract][Full Text] [Related]
38. Time to onset and duration of action of the antihistamine bepotastine besilate ophthalmic solutions 1.0% and 1.5% in allergic conjunctivitis: a phase III, single-center, prospective, randomized, double-masked, placebo-controlled, conjunctival allergen challenge assessment in adults and children. Abelson MB; Torkildsen GL; Williams JI; Gow JA; Gomes PJ; McNamara TR; Clin Ther; 2009 Sep; 31(9):1908-21. PubMed ID: 19843481 [TBL] [Abstract][Full Text] [Related]